Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kilannin Krysiak

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Experimental Hematology|January 1, 2015
Reduced levels of Hspa9 attenuate Stat5 activation in mouse B cellsKilannin Krysiak, Justin F Tibbitts, Jin Shao, et al.
Plos One|February 9, 2017
Knockdown of HSPA9 induces TP53-dependent apoptosis in human hematopoietic progenitor cellsTuoen Liu, Kilannin Krysiak, Cara Lunn Shirai, et al.
Journal of Medicinal Chemistry|October 30, 2007
Activity of sulfonium bisphosphonates on tumor cell linesYonghui Zhang, Michael P Hudock, Kilannin Krysiak, et al.
Blood|December 3, 2010
Knockdown of Hspa9, a del(5q31.2) gene, results in a decrease in hematopoietic progenitors in miceTim H-P Chen, Amal Kambal, Kilannin Krysiak, et al.
Bioorganic & Medicinal Chemistry|September 16, 2008
Bisphosphonate inhibitors of ATP-mediated HIV-1 reverse transcriptase catalyzed excision of chain-terminating 3'-azido, 3'-deoxythymidine: a QSAR investigationYongcheng Song, Julian M W Chan, Zev Tovian, et al.
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing|December 21, 2022
Accessing clinical-grade genomic classification data through the ClinGen Data PlatformKaren P Dalton, Heidi L Rehm, Matt W Wright, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
Searching the Druggable Genome using Large Language ModelsLars Schimmelpfennig, Matthew Cannon, Quentin Cody, et al.
Genome Medicine|December 5, 2019
Text-mining clinically relevant cancer biomarkers for curation into the CIViC databaseJake Lever, Martin R Jones, Arpad M Danos, et al.
Cell Reports|August 8, 2019
A Spontaneous Aggressive ERα+ Mammary Tumor Model Is Driven by Kras ActivationKatie M Campbell, Kathleen A O'Leary, Debra E Rugowski, et al.
Clinical Genetics|December 4, 2024
Comprehensive Analysis of TEK Variants in Patients With Vascular MalformationsReza Ghasemi, Meagan M Corliss, Kevin M Bowling, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Experimental Hematology|January 1, 2015
Reduced levels of Hspa9 attenuate Stat5 activation in mouse B cellsKilannin Krysiak, Justin F Tibbitts, Jin Shao, et al.
Plos One|February 9, 2017
Knockdown of HSPA9 induces TP53-dependent apoptosis in human hematopoietic progenitor cellsTuoen Liu, Kilannin Krysiak, Cara Lunn Shirai, et al.
Journal of Medicinal Chemistry|October 30, 2007
Activity of sulfonium bisphosphonates on tumor cell linesYonghui Zhang, Michael P Hudock, Kilannin Krysiak, et al.
Blood|December 3, 2010
Knockdown of Hspa9, a del(5q31.2) gene, results in a decrease in hematopoietic progenitors in miceTim H-P Chen, Amal Kambal, Kilannin Krysiak, et al.
Bioorganic & Medicinal Chemistry|September 16, 2008
Bisphosphonate inhibitors of ATP-mediated HIV-1 reverse transcriptase catalyzed excision of chain-terminating 3'-azido, 3'-deoxythymidine: a QSAR investigationYongcheng Song, Julian M W Chan, Zev Tovian, et al.
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing|December 21, 2022
Accessing clinical-grade genomic classification data through the ClinGen Data PlatformKaren P Dalton, Heidi L Rehm, Matt W Wright, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
Searching the Druggable Genome using Large Language ModelsLars Schimmelpfennig, Matthew Cannon, Quentin Cody, et al.
Genome Medicine|December 5, 2019
Text-mining clinically relevant cancer biomarkers for curation into the CIViC databaseJake Lever, Martin R Jones, Arpad M Danos, et al.
Cell Reports|August 8, 2019
A Spontaneous Aggressive ERα+ Mammary Tumor Model Is Driven by Kras ActivationKatie M Campbell, Kathleen A O'Leary, Debra E Rugowski, et al.
Clinical Genetics|December 4, 2024
Comprehensive Analysis of TEK Variants in Patients With Vascular MalformationsReza Ghasemi, Meagan M Corliss, Kevin M Bowling, et al.
Pageof 5